Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Actemra Access: Roche Open To Partnering Patent Pools

Jul 16 2021

• By Anju Ghangurde

Coronavirus Variant Emerging/Mutated SARS-CoV-2 — Broadening Access To COVID-19 Therapies • Source: Alamy

Related Content

Roche Tocilizumab IP Relaxation Does Not Go Far Enough

Jul 13 2021

Coronavirus Update: Once Written Off, Roche's Actemra Finally Gets EUA In COVID-19

Jun 28 2021

How Cipla Is Shaping Lung Leadership Beyond Asthma, AMR Plans

Jun 14 2021

Roche Under Fire Over ‘Unaffordable’ COVID-19 Therapy Actemra

Jul 07 2021

Related Companies

Roche Holding AG

Regeneron Pharmaceuticals, Inc.

Cipla Limited

Hetero Drugs Ltd.

Biocon, Ltd.

Chugai Pharmaceutical Co., Ltd.

Additional Topics

India Asia Pacific Commercial Coronavirus COVID-19 Intellectual Property BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window